Side-by-side comparison
BPC-157 vs TB-500
Built from the published sections of each compound page. Empty cells mean that part hasn’t been published yet, not that there’s nothing to know.
Informational only. This doesn’t rank the two, recommend either, or suggest using them together.
Regulatory status
- BPC-157
- Research only (US)
- TB-500
- Research only (US)
Class
- BPC-157
- Synthetic 15-amino-acid peptide (pentadecapeptide) from human gastric juice
- TB-500
- Synthetic 7-amino-acid fragment of thymosin beta-4 (Ac-LKKTETQ)
Half-life
- BPC-157
- ~30 minutes (parenteral)
- TB-500
- ~2 hours
Evidence
- BPC-157
- Not published yet
- TB-500
- Not published yet
How it works
- BPC-157
- Not published yet
- TB-500
- Not published yet
Research evidence
- BPC-157
- Not published yet
- TB-500
- Not published yet
Side effects
- BPC-157
- Not published yet
- TB-500
- Not published yet
Contraindications
- BPC-157
- Not published yet
- TB-500
- Not published yet
Monitoring markers
- BPC-157
- Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP), Fasting Blood Glucose, High-Sensitivity C-Reactive Protein (hs-CRP), IGF-1 (Insulin-like Growth Factor 1)
- TB-500
- Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP), High-Sensitivity C-Reactive Protein (hs-CRP), IGF-1 (Insulin-like Growth Factor 1)
Main uncertainties
- BPC-157
- Still in editorial review: quick overview, what it is, what researchers are studying, how it works.
- TB-500
- Still in editorial review: quick overview, what it is, what researchers are studying, how it works.
Expert disagreements
- BPC-157
- Not published yet
- TB-500
- Not published yet
Questions?
Send me a message and I’ll point you to the right guide or source.